−Removed: Office and Lab Space Leases
−Removed: In December 2020, we entered
−Removed: into an agreement to lease approximately 2,823 square feet of office space and 1,807 square feet of laboratory space located at 11555
−Removed: Sorrento Valley Road, Suite 203, San Diego, California 92121 and 11585 Sorrento Valley Road, Suite 109, San Diego, California 92121, respectively.
+Added: Office, Lab and Manufacturing Space Leases
+Added: In December 2020, we entered into
+Added: an agreement to lease approximately 2,823 square feet of office space and 1,807 square feet of laboratory space located at 11555 Sorrento
+Added: Valley Road, Suite 203, San Diego, California 92121 and 11575 Sorrento Valley Road, Suite 200, San Diego, California 92121, respectively.
The agreement carries a term of 63 months and we took possession of the office space effective October 1, 2021.
We took possession of
−Removed: the lab space effective January 1, 2022.
−Removed: On October 1, 2021, we recorded
−Removed: a $343,633 right-of-use lease asset and associated lease liability related to the office space component of the lease based on the present
−Removed: value of lease payments over the expected lease term of 63 months, discounted using our estimated incremental borrowing rate of 4.25%.
−Removed: The current monthly base rent under the office component of the lease is $6,121.
−Removed: During the three months ended
−Removed: March 31, 2022, we recorded a $400,797 right-of-use lease asset and associated lease liability related to the lab space component of the
−Removed: lease based on the present value of lease payments over the expected lease term of 63 months, discounted using our estimated incremental
+Added: the laboratory space effective January 1, 2022.
+Added: In October 2021, we entered into another lease for approximately 2,655 square feet of
+Added: space to house our manufacturing operations located at 11588 Sorrento Valley Road, San Diego, California 92121.
+Added: The term is for 55 months
+Added: and we took possession of the manufacturing space in August 2022.
+Added: The current monthly base rent under the office and laboratory component
+Added: of the lease is $13,772.
+Added: The current monthly base rent under the manufacturing component of the lease is $12,080.
+Added: During the fiscal year ended
+Added: March 31, 2023, we recorded a $625,471 right-of-use lease asset and associated lease liability related to the manufacturing space component
+Added: of the lease based on the present value of lease payments over the expected lease term of 55 months, discounted using our estimated incremental
borrowing rate of 4.25%.
−Removed: The initial monthly base rent under the lab component of the lease is $7,456.
−Removed: Manufacturing Space Lease
−Removed: In October 2021, we entered into another lease
−Removed: for an initial period of 58 months for (i) approximately 22,260 square feet of space located at 11588 Sorrento Valley Road, San Diego,
−Removed: California 92121, or the Building, and (ii) 2,655 square feet of space located in the Building and commonly known as Suite 18, to house
−Removed: our manufacturing operations.
−Removed: That manufacturing space is located at 11588 Sorrento Valley Road, San Diego, California 92121 and it is
−Removed: near our new lab and office locations.
−Removed: We anticipate that the landlord will complete construction on this new space in the third calendar
−Removed: quarter of 2022 and we will take occupancy at that time.
−Removed: The initial base rent for the manufacturing space will be $12,080 per month.
−Removed: Based on the assumptions that
−Removed: we used to calculate the right-of-use lease asset for the new office and lab spaces, we estimate that we will record a right- of- use
−Removed: lease asset of $614,240 and associated lease liability for the manufacturing space lease when we take possession of that space.
+Added: The office, lab and manufacturing
+Added: leases are coterminous with a remaining term of 48 months.
+Added: The weighted average discount rate is 4.25%.
+Added: As of our March 31, 2023 balance
+Added: sheet, we have a right-of-use lease asset of $1,151,909.
+Added: following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next
+Added: four fiscal years.
+Added: All of our leases conterminously expire during the fiscal year ending March 31, 2027.
+Added: Fiscal Year Ended March 31,
+Added: Total minimum lease payments
+Added: Less amount representing imputed interest
+Added: Present value of minimum lease payments
Mobile Clean Room
−Removed: In addition, we rent a mobile
−Removed: clean room on a short term, month-to-month basis, where we house our manufacturing operations until our permanent manufacturing space
−Removed: is completed.
−Removed: We also rent the land on which the mobile clean room is based on a month-to-month basis.
−Removed: The mobile clean room is located
−Removed: on leased land near our office and lab and we pay $2,000 per month for the right to locate it there.
−Removed: We paid approximately $189,000 in
−Removed: rent expense to lease the mobile clean room located on this space during the fiscal year ended March 31, 2022.
+Added: In addition, we rented a
+Added: mobile clean room on a short term, month-to-month basis, where we housed our manufacturing operations until our permanent manufacturing
+Added: space was completed.
+Added: The mobile clean room was located on leased land near our office and lab and we paid $2,000 per month for the right
+Added: to locate it there.
+Added: We paid approximately $168,171 in total rent expense to lease the mobile clean room located on this space during
+Added: the fiscal year ended March 31, 2023.
+Added: The arrangement was terminated in September 2022 and the mobile clean room was returned to the
+Added: vendor that leased it to us.
+Added: Overall, our rent expense, which is included in general and administrative expenses, approximated $519,000
+Added: and $401,000 for the fiscal years ended March 31, 2023 and 2022, respectively.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.